Beneficial Effect of Efonidipine, an L- and T-Type Dual Calcium Channel Blocker, on Heart Rate and Blood Pressure in Patients With Mild-to-Moderate Essential Hypertension |
Oh, Il-Young
(Department of Internal Medicine, Seoul National University College of Medicine, Bundang Hospital)
Seo, Myung-Ki (Department of Internal Medicine, Seoul National University College of Medicine) Lee, Hae-Young (Department of Internal Medicine, Seoul National University College of Medicine) Kim, Soon-Gil (Department of Internal Medicine, Hanyang University College of Medicine, Guri Hospital) Kim, Ki-Sik (Department of Internal Medicine, Daegu Catholic University College of Medicine) Kim, Won-Ho (Department of Internal Medicine, Chonbuk National University College of Medicine) Hyon, Min-Soo (Department of Internal Medicine, Soonchunhyang University College of Medicine) Han, Kyoo-Rok (Department of Internal Medicine, Hallym University College of Medicine) Lim, Se-Joong (Department of Internal Medicine, Yonsei University College of Medicine, Gangnam Severance Hospital) Kim, Cheol-Ho (Department of Internal Medicine, Seoul National University College of Medicine, Bundang Hospital) |
1 | Jouven X, Empana JP, Schwartz PJ, Desnos M, Courbon D, Ducimetiere P. Heart-rate profile during exercise as a predictor of sudden death. N Engl J Med 2005;352:1951-8. DOI ScienceOn |
2 | Chung JW, Lee HY, Kim CH, et al. Losartan/hydrochlorothiazide fixed combination versus amlodipine monotherapy in Korean patients with mild to moderate hypertension. Korean Circ J 2009;39:151-6. DOI ScienceOn |
3 | Psaty BM, Heckbert SR, Koepsell TD, et al. The risk of myocardial infarction associated with antihypertensive drug therapies. JAMA 1995;274:620-5. DOI ScienceOn |
4 | Tanaka H, Shigenobu K. Efonidipine hydrochloride: a dual blocker of L- and T-type ca(2+) channels. Cardiovasc Drug Rev 2002;20:81-92. |
5 | Palatini P, Benetos A, Julius S. Impact of increased heart rate on clinical outcomes in hypertension: implications for antihypertensive drug therapy. Drugs 2006;66:133-44. DOI ScienceOn |
6 | Kim DW, Seo JD, Cho SW, et al. Antihypertensive efficacy and safety of perindopril versus nifedipine in high salt intake essential hypertensives: a double-blind parallel group study. Korean Circ J 1994;24:156-63. DOI |
7 | Lindholm LH, Carlberg B, Samuelsson O. Should beta blockers remain first choice in the treatment of primary hypertension: a meta-analysis. Lancet 2005;366:1545-53. DOI |
8 | Morimoto S, Jo F, Maki K, Iwasaka T. Effects of efonidipine hydrochloride on heart rate and circulatory changes due to stress. Clin Exp Hypertens 2009;31:83-91. DOI ScienceOn |
9 | Kinoshita H, Kuwahara K, Takano M, et al. T-type Ca2+ channel blockade prevents sudden death in mice with heart failure. Circulation 2009;120:743-52. DOI ScienceOn |
10 | Bloch MJ. British hypertension society recommends that beta-blockers are no longer indicated as initial treatment of hypertension: has the pendulum swung too far? J Clin Hypertens 2007;9:99-102. DOI ScienceOn |
11 | Furukawa T, Nukada T, Miura R, et al. Differential blocking action of dihydropyridine Ca2+ antagonists on a T-type Ca2+ channel (alpha1G) expressed in Xenopus oocytes. J Cardiovasc Pharmacol 2005;45:241-6. DOI ScienceOn |
12 | Furukawa T, Yamakawa T, Midera T, Sagawa T, Mori Y, Nukada T. Selectivities of dihydropyridine derivatives in blocking Ca(2+) channel subtypes expressed in Xenopus oocytes. J Pharmacol Exp Ther 1999;291:464-73. |
13 | Goldbourt U, Behar S, Reicher-Reiss H, Zion M, Mandelzweig L, Kaplinsky E. Early administration of nifedipine in suspected acute myocardial infarction. The Secondary Prevention Reinfarction Israel Nifedipine Trial 2 Study. Arch Intern Med 1993;153:345-53. DOI ScienceOn |
14 | Fox K, Borer JS, Camm AJ, et al. Resting heart rate in cardiovascular disease. J Am Coll Cardiol 2007;50:823-30. DOI ScienceOn |
15 | Cha DH, Cha YS, Kook JH, et al. Clinical efficacy of carvedilol in patients with moderate to severe congestive heart failure. Korean Circ J 1998;28:523-31. |
16 | The Israeli Sprint Study Group. Secondary prevention reinfarction Israeli nifedipine trial (SPRINT): a randomized intervention trial of nifedipine in patients with acute myocardial infarction. Eur Heart J 1988;9:354-64. |
17 | Gillman MW, Kannel WB, Belanger A, D'Agostino RB. Influence of heart rate on mortality among persons with hypertension: the Framingham Study. Am Heart J 1993;125:1148-54. DOI ScienceOn |
18 | Furberg CD, Psaty BM, Meyer JV. Nifedipine: Dose-related increase in mortality in patients with coronary heart disease. Circulation 1995;92:1326-31. DOI ScienceOn |
19 | Diaz A, Bourassa MG, Guertin MC, Tardif JC. Long-term prognostic value of resting heart rate in patients with suspected or proven coronary artery disease. Eur Heart J 2005;26:967-74. DOI ScienceOn |
20 | Palatini P, Benetos A, Grassi G, et al. Identification and management of the hypertensive patient with elevated heart rate: statement of a European Society of Hypertension Consensus Meeting. J Hypertens 2006;24:603-10. DOI ScienceOn |
21 | Tanaka T, Tsutamoto T, Sakai H, Fujii M, Yamamoto T, Horie M. Comparison of the effects of efonidipine and amlodipine on aldosterone in patients with hypertension. Hypertens Res 2007;30:691-7. DOI ScienceOn |
22 | Shimizu M, Ogawa K, Sasaki H, et al. Effects of efonidipine, an L- and T-Type dual calcium channel blocker, on heart rate and blood pressure in patients with mild to severe hypertension: an uncontrolled, openlabel pilot study. Current Ther Res 2003;64:707-14. DOI ScienceOn |
23 | Masumiya H, Shijuku T, Tanaka H, Shigenobu K. Inhibition of myocardial L- and T-type Ca2+ currents by efonidipine: possible mechanism for its chronotropic effect. Eur J Pharmacol 1998;349:351-7. DOI |
24 | Hagiwara N, Irisawa H, Kameyama M. Contribution of two types of calcium currents to the pacemaker potentials of rabbit sino-atrial node cells. J Physiol 1988;395:233-53. DOI |